To counteract the phagocytic inhibition caused by SIRPα upregulation in CAR-M cells, we introduced a specific shRNA to silence SIRPα, which resulted in improved phagocytosis and enhanced the tumor-killing efficiency of CAR-shSIRPα macrophages. Here, SIRPA is linked to neoplasm.